Unknown

Dataset Information

0

Validation of the Hsp70-Bag3 protein-protein interaction as a potential therapeutic target in cancer.


ABSTRACT: Hsp70 is a stress-inducible molecular chaperone that is required for cancer development at several steps. Targeting the active site of Hsp70 has proven relatively challenging, driving interest in alternative approaches. Hsp70 collaborates with the Bcl2-associated athanogene 3 (Bag3) to promote cell survival through multiple pathways, including FoxM1. Therefore, inhibitors of the Hsp70-Bag3 protein-protein interaction (PPI) may provide a noncanonical way to target this chaperone. We report that JG-98, an allosteric inhibitor of this PPI, indeed has antiproliferative activity (EC50 values between 0.3 and 4 ?mol/L) across cancer cell lines from multiple origins. JG-98 destabilized FoxM1 and relieved suppression of downstream effectors, including p21 and p27. On the basis of these findings, JG-98 was evaluated in mice for pharmacokinetics, tolerability, and activity in two xenograft models. The results suggested that the Hsp70-Bag3 interaction may be a promising, new target for anticancer therapy.

SUBMITTER: Li X 

PROVIDER: S-EPMC4456214 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Validation of the Hsp70-Bag3 protein-protein interaction as a potential therapeutic target in cancer.

Li Xiaokai X   Colvin Teresa T   Rauch Jennifer N JN   Acosta-Alvear Diego D   Kampmann Martin M   Dunyak Bryan B   Hann Byron B   Aftab Blake T BT   Murnane Megan M   Cho Min M   Walter Peter P   Weissman Jonathan S JS   Sherman Michael Y MY   Gestwicki Jason E JE  

Molecular cancer therapeutics 20150106 3


Hsp70 is a stress-inducible molecular chaperone that is required for cancer development at several steps. Targeting the active site of Hsp70 has proven relatively challenging, driving interest in alternative approaches. Hsp70 collaborates with the Bcl2-associated athanogene 3 (Bag3) to promote cell survival through multiple pathways, including FoxM1. Therefore, inhibitors of the Hsp70-Bag3 protein-protein interaction (PPI) may provide a noncanonical way to target this chaperone. We report that J  ...[more]

Similar Datasets

| S-EPMC4174322 | biostudies-literature
| S-EPMC7379509 | biostudies-literature
| S-EPMC2783218 | biostudies-literature
| S-EPMC8744729 | biostudies-literature
| S-EPMC6297355 | biostudies-literature
| S-EPMC2377073 | biostudies-other
| S-EPMC2816663 | biostudies-literature
| S-EPMC6064996 | biostudies-literature
| S-EPMC5797028 | biostudies-literature
| S-EPMC7019160 | biostudies-literature